Archive Results

  • Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx

    Find our Biolaminin® 521 LN in the new PluriKit™ by PluriStyx We are proud to have been chosen by PluriStyx […]
  • Webinar: Treating Blindness with Stem Cell Therapies

    How close are we to one-shot stem cell therapies for eye disease? What are the critical factors for successful translation to the clinic? Join us for the panel discussion!
  • BioLamina AB appoints Klaus Langhoff-Roos as new CEO.

    Stockholm August 15, 2024 BioLamina appoints Klaus Langhoff-Roos as new CEO. BioLamina AB, a leading maker of reagents for stem […]
  • Meet us at our next events!

    Meet us at our next events Meet us to discuss how we can help you revolutionize cell culture. We will […]
  • BioLamina AB announces release of Biolaminin® 521 LN first batches from new production suite

    Stockholm May 23rd, 2023 BioLamina AB announces release of Biolaminin® 521 LN first batches from new production suite BioLamina announces […]